Elite Pharmaceuticals Inc (ELTP)
0.6168
0.00 (0.00%)
USD |
OTCM |
Nov 22, 15:59
Elite Pharmaceuticals 1 Year Total Returns (Daily): 308.4% for Nov. 21, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 21, 2024 | 308.4% |
November 20, 2024 | 320.5% |
November 19, 2024 | 344.1% |
November 18, 2024 | 337.7% |
November 15, 2024 | 287.2% |
November 14, 2024 | 331.4% |
November 13, 2024 | 399.7% |
November 12, 2024 | 387.0% |
November 11, 2024 | 370.4% |
November 08, 2024 | 332.8% |
November 07, 2024 | 327.3% |
November 06, 2024 | 335.3% |
November 05, 2024 | 311.1% |
November 04, 2024 | 311.4% |
November 01, 2024 | 306.0% |
October 31, 2024 | 279.0% |
October 30, 2024 | 254.8% |
October 29, 2024 | 333.0% |
October 28, 2024 | 383.1% |
October 25, 2024 | 339.1% |
October 24, 2024 | 297.5% |
October 23, 2024 | 218.2% |
October 22, 2024 | 333.5% |
October 21, 2024 | 409.4% |
October 18, 2024 | 479.8% |
Date | Value |
---|---|
October 17, 2024 | 400.0% |
October 16, 2024 | 385.0% |
October 15, 2024 | 360.2% |
October 14, 2024 | 336.6% |
October 11, 2024 | 341.8% |
October 10, 2024 | 318.1% |
October 09, 2024 | 318.1% |
October 08, 2024 | 322.3% |
October 07, 2024 | 317.3% |
October 04, 2024 | 321.2% |
October 03, 2024 | 310.6% |
October 02, 2024 | 347.5% |
October 01, 2024 | 313.5% |
September 30, 2024 | 313.6% |
September 27, 2024 | 326.2% |
September 26, 2024 | 332.6% |
September 25, 2024 | 331.1% |
September 24, 2024 | 335.2% |
September 23, 2024 | 330.5% |
September 20, 2024 | 369.2% |
September 19, 2024 | 381.8% |
September 18, 2024 | 373.1% |
September 17, 2024 | 390.4% |
September 16, 2024 | 399.7% |
September 13, 2024 | 414.4% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-53.03%
Minimum
Nov 16 2021
556.0%
Maximum
Jan 18 2024
69.06%
Average
-11.96%
Median
1 Year Total Returns (Daily) Benchmarks
Biomarin Pharmaceutical Inc | -27.95% |
BioCardia Inc | -77.41% |
Zevra Therapeutics Inc | 102.4% |
Verrica Pharmaceuticals Inc | -73.17% |
Terns Pharmaceuticals Inc | 51.46% |